Protagenic Therapeutics, Inc. Common Stock Forecast
Volatile ride for Protagenic Therapeutics, Inc. Common stock price on Friday moving between $1.32 and $1.48
(Updated on Apr 26, 2024)
The Protagenic Therapeutics, Inc. Common stock price fell by -11.71% on the last day (Friday, 26th Apr 2024) from $1.57 to $1.39. During the last trading day the stock fluctuated 12.12% from a day low at $1.32 to a day high of $1.48. The price has fallen in 6 of the last 10 days and is down by -3.82% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -6 thousand shares and in total, 10 thousand shares were bought and sold for approximately $14.49 thousand.
The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.30 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 66.49% during the next 3 months and, with a 90% probability hold a price between $2.17 and $3.50 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
PTIX Signals & Forecast
There are few to no technical positive signals at the moment. The Protagenic Therapeutics, Inc. Common stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.44 and $1.45. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, March 27, 2024, and so far it has fallen -23.90%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Protagenic Therapeutics, Inc. Common stock
Protagenic Therapeutics, Inc. Common finds support from accumulated volume at $1.35 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.160 between high and low, or 12.12%. For the last week the stock has had daily average volatility of 22.12%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (PTIX) For The Upcoming Trading Day Of Monday 29th
For the upcoming trading day on Monday, 29th we expect Protagenic Therapeutics, Inc. Common Stock to open at $1.40, and during the day (based on 14 day Average True Range), to move between $1.17 and $1.60, which gives a possible trading interval of +/-$0.213 (+/-15.36%) up or down from last closing price. If Protagenic Therapeutics, Inc. Common Stock takes out the full calculated possible swing range there will be an estimated 30.71% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $1.35 (2.53%) than the resistance at $1.43 (3.25%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Protagenic Therapeutics, Inc. Common Stock stock A Buy?
The Protagenic Therapeutics, Inc. Common stock holds several negative signals and despite the positive trend, we believe Protagenic Therapeutics, Inc. Common will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
Current score: -3.551 Sell Candidate Unchanged
Predicted Opening Price for Protagenic Therapeutics, Inc. Common Stock of Monday, April 29, 2024
| Fair opening price April 29, 2024 | Current price |
|---|---|
| $1.40 ( 0.722%) | $1.39 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for PTIX
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 1.56 | 12.27 % | |
| R2 | 1.49 | 7.86 % | ||
| R1 | 1.46 | 5.14 % | ||
| Current price: | 1.39 | |||
| Support | S1 | 1.33 | -3.69 % | |
| S2 | 1.30 | -6.42 % | ||
| S3 | 1.24 | -10.83 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 1.61 | 16.25 % | |
| R2 | 1.57 | 13.36 % | ||
| R1 | 1.43 | 3.25 % | ||
| Current price | 1.39 | |||
| Support | S1 | 1.35 | -2.53% | |
| S2 | 1.30 | -6.50% | ||
| S3 | 1.16 | -16.25% |
FAQ
Click here for our free guide on how to buy Protagenic Therapeutics, Inc. Common Stock Stock.
